Your browser doesn't support javascript.
loading
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer.
Adeegbe, Dennis O; Liu, Yan; Lizotte, Patrick H; Kamihara, Yusuke; Aref, Amir R; Almonte, Christina; Dries, Ruben; Li, Yuyang; Liu, Shengwu; Wang, Xiaoen; Warner-Hatten, Tiquella; Castrillon, Jessica; Yuan, Guo-Cheng; Poudel-Neupane, Neermala; Zhang, Haikuo; Guerriero, Jennifer L; Han, Shiwei; Awad, Mark M; Barbie, David A; Ritz, Jerome; Jones, Simon S; Hammerman, Peter S; Bradner, James; Quayle, Steven N; Wong, Kwok-Kin.
Afiliación
  • Adeegbe DO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Liu Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lizotte PH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kamihara Y; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Aref AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Almonte C; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Dries R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Liu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wang X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Warner-Hatten T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Castrillon J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Yuan GC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Poudel-Neupane N; Harvard Chan School of Public Health, Boston, Massachusetts.
  • Zhang H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Guerriero JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Han S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ritz J; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Jones SS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hammerman PS; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Bradner J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Quayle SN; Acetylon Pharmaceuticals, Inc., Boston, Massachusetts.
  • Wong KK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer Discov ; 7(8): 852-867, 2017 08.
Article en En | MEDLINE | ID: mdl-28408401

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Histona Desacetilasas / Ácidos Hidroxámicos Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Histona Desacetilasas / Ácidos Hidroxámicos Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Año: 2017 Tipo del documento: Article